Finance

Beta
Lists
MBX:TSE
Microbix Biosystems Inc
CA$0.28
0.00%
(0.00) 1D
Jun 11, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MBX...
Open
CA$0.29
High
CA$0.30
Low
CA$0.28
Mkt. cap
39.89M
Avg. vol.
54.62K
Volume
24.71K
52-wk high
CA$0.34
52-wk low
CA$0.21
EPS
-CA$0.04
Beta
0.59
Shares outstanding
137.50M
No. of employees
70
Open
CA$0.29
High
CA$0.30
Low
CA$0.28
Mkt. cap
39.89M
Avg. vol.
54.62K
Volume
24.71K
52-wk high
CA$0.34
52-wk low
CA$0.21
EPS
-CA$0.04
Beta
0.59
Shares outstanding
137.50M
No. of employees
70
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to MBX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for MBX in the last 3 months.
Highest
Current CA$0.28
CA$0.40 (+40.35%)
Average
CA$0.40 (+40.35%)
Lowest
CA$0.40 (+40.35%)
News stories
From sources across the web
About Microbix Biosystems Inc
CEO-
Employees70
Founded1988
HeadquartersMississauga, Ontario, Canada
SectorBiotechnology
Last report
May 14, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -
Revenue / Est. (USD)
2.46M / 3.37M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.47M
3.74M
4.22M
3.38M
Cost of goods sold
2.06M
2.23M
2.49M
1.75M
Cost of revenue
2.06M
2.23M
2.49M
1.75M
Research and development expenses
591.56K
626.76K
557.07K
601.29K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.15M
2.30M
2.13M
2.29M
Operating expense
2.74M
2.92M
2.68M
2.89M
Total operating expenses
4.80M
5.15M
5.17M
4.64M
Operating income
-1.33M
-1.41M
-949.19K
-1.26M
Other non operating income
-1.00
1.00
1.00
-
EBT including unusual items
-1.64M
-1.54M
-1.17M
-1.43M
EBT excluding unusual items
-1.64M
-1.54M
-1.17M
-1.43M
Income tax expense
-
-55.73K
-
-
Effective tax rate
-
3.63%
-
-
Other operating expenses
-
-
-
-
Net income
-1.64M
-1.48M
-1.17M
-1.43M
Net profit margin
-47.31%
-39.54%
-27.67%
-42.35%
Earnings per share
-
-
-
-
Interest and investment income
68.63K
74.68K
71.52K
62.37K
Interest expense
-225.12K
-243.00K
-251.72K
-256.38K
Net interest expenses
-156.49K
-168.32K
-180.20K
-194.01K
Depreciation and amortization charges
-
-
-
-
EBITDA
-884.77K
-1.04M
-592.76K
-798.84K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more